NCT01024192View on ClinicalTrials.gov

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Sleep Disorders
Interventions
DRUG

ZOLPIDEM SL800750

"Pharmaceutical form: Zopidem 12.5 mg tablets~Route of administration: Oral~Dose regimen:One tablet at bed time and as needed (the patients choose which night they take the tablet without limit of number of nights)"

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Col. Coyoacan

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY